3989-35-3 Usage
Uses
Used in Ceramics Industry:
RARECHEM AL BF 0508 is used as a raw material in the production of ceramics for its high purity and thermal stability, contributing to the creation of high-quality ceramic products with improved performance.
Used in Glass Industry:
In the glass industry, RARECHEM AL BF 0508 is used as an additive to enhance the properties of glass, such as increasing its strength and durability, and improving its resistance to thermal shock.
Used in Metal Alloys Production:
RARECHEM AL BF 0508 is used as an alloying element in the production of metal alloys to improve their mechanical properties, such as strength and hardness, while maintaining good ductility and corrosion resistance.
Used in High-Temperature Environments:
Due to its high thermal stability and resistance to corrosion, RARECHEM AL BF 0508 is used in components and applications that require operation in high-temperature environments, ensuring reliable performance and longevity.
Used in Manufacturing Components Requiring High Strength and Durability:
RARECHEM AL BF 0508 is utilized in the manufacturing of components that demand high strength and durability, such as in aerospace, automotive, and heavy machinery industries, due to its strong mechanical properties and resistance to wear and tear.
Check Digit Verification of cas no
The CAS Registry Mumber 3989-35-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,8 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3989-35:
(6*3)+(5*9)+(4*8)+(3*9)+(2*3)+(1*5)=133
133 % 10 = 3
So 3989-35-3 is a valid CAS Registry Number.
3989-35-3Relevant academic research and scientific papers
SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
-
Page/Page column 140, (2018/04/23)
Substituted 1 H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.
